Incannex Healthcare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Incannex Healthcare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 27.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Nov 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 0 | -33 | N/A | N/A | 1 |
6/30/2023 | 1 | -20 | -16 | -16 | N/A |
3/31/2023 | 1 | -19 | -16 | -16 | N/A |
12/31/2022 | 1 | -18 | -16 | -16 | N/A |
9/30/2022 | 1 | -17 | -14 | -14 | N/A |
6/30/2022 | 1 | -15 | -13 | -13 | N/A |
3/31/2022 | 1 | -14 | -11 | -11 | N/A |
12/31/2021 | 1 | -13 | -9 | -9 | N/A |
9/30/2021 | 1 | -12 | -8 | -8 | N/A |
6/30/2021 | 2 | -11 | -7 | -7 | N/A |
12/31/2020 | 2 | -6 | -5 | -5 | N/A |
9/30/2020 | 1 | -5 | -5 | -5 | N/A |
6/30/2020 | 1 | -4 | -4 | -4 | N/A |
12/31/2019 | 0 | -2 | -2 | -2 | N/A |
9/30/2019 | 0 | -2 | -2 | -2 | N/A |
6/30/2019 | 0 | -1 | -2 | -2 | N/A |
3/31/2019 | 1 | -3 | -3 | -2 | N/A |
12/31/2018 | 1 | -3 | -3 | -3 | N/A |
9/30/2018 | 1 | -3 | -3 | -3 | N/A |
6/30/2018 | 1 | -3 | -3 | -3 | N/A |
3/31/2018 | 1 | -3 | -3 | -3 | N/A |
12/31/2017 | 1 | -3 | -3 | -3 | N/A |
9/30/2017 | 0 | -12 | -3 | -3 | N/A |
6/30/2017 | 0 | -21 | -3 | -3 | N/A |
3/31/2017 | 0 | -20 | N/A | -2 | N/A |
12/31/2016 | 0 | -19 | N/A | -2 | N/A |
9/30/2016 | 0 | -10 | N/A | -1 | N/A |
6/30/2016 | 0 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if IHL's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if IHL's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if IHL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if IHL's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if IHL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IHL's Return on Equity is forecast to be high in 3 years time